63323-132 : Mitoxantrone 2 mg/ml Intravenous Injection, Solution
| NDC: | 63323-132 |
| Labeler: | App Pharmaceuticals, LLC |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Mitoxantrone |
| Dosage Form: | Intravenous Injection, Solution |
| Application #: | ANDA077496 |
| Rev. Date: |
NDC Package Codes:
- 63323-132-10: 1 VIAL, MULTI‑DOSE IN 1 BOX (63323‑132‑10) > 10 ML IN 1 VIAL, MULTI‑DOSE
- 63323-132-12: 1 VIAL IN 1 BOX (63323‑132‑12) > 12.5 ML IN 1 VIAL
- 63323-132-15: 1 VIAL, MULTI‑DOSE IN 1 BOX (63323‑132‑15) > 15 ML IN 1 VIAL, MULTI‑DOSE
Active Ingredients:
- Mitoxantrone Hydrochloride
Dosage Strength:
- 2 mg/mL
Pharmaceutical Classes:
- Topoisomerase Inhibitor [EPC]
- Topoisomerase Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 0703-4680 Mitoxantrone 2 mg/ml Intravenous Injection, Solution, Concentrate by Teva Parenteral Medicines, Inc
- 0703-4685 Mitoxantrone 2 mg/ml Intravenous Injection, Solution, Concentrate by Teva Parenteral Medicines, Inc
- 0703-4686 Mitoxantrone 2 mg/ml Intravenous Injection, Solution, Concentrate by Teva Parenteral Medicines, Inc
- 55390-083 Mitoxantrone 2 mg/ml Intravenous Injection, Solution by Bedford Laboratories
- 55390-084 Mitoxantrone 2 mg/ml Intravenous Injection, Solution by Bedford Laboratories
- 55390-085 Mitoxantrone 2 mg/ml Intravenous Injection, Solution by Bedford Laboratories
- 61703-343 Mitoxantrone 2 mg/ml Intravenous Injection, Solution, Concentrate by Hospira Worldwide, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 63323-130Next: 63323-134 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.